Aesculap Implant Systems received FDA regulatory approval for its S4 Cervical Occipital Plating System, according to an Aesculap news release.
The S4 System is used to promote spinal fusion of the cervical thoracic spine and accipito-cervico-thoracic junction in patients with degenerative disease or fracture, according to the release.
Read the Aesculap release on the FDA-approved S4 system.
Read more coverage on Aesculap:
- Aesculap Launches New Generation Surgical System
- Aesculap's A-FIX Spinal System Receives FDA Clearance
- Aesculap Launches New Generation Surgical System
The S4 System is used to promote spinal fusion of the cervical thoracic spine and accipito-cervico-thoracic junction in patients with degenerative disease or fracture, according to the release.
Read the Aesculap release on the FDA-approved S4 system.
Read more coverage on Aesculap:
- Aesculap Launches New Generation Surgical System
- Aesculap's A-FIX Spinal System Receives FDA Clearance
- Aesculap Launches New Generation Surgical System